In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Dans son livre « Service public ou barbarie », l’énarque et créateur du collectif Nos services publics invite la gauche à réinventer l’idéal porté par ce bien commun en le rapprochant des usagers et ...
Recent transactionsRecursion Pharmaceuticals insiders reported 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with the remaining 2 transactions valued at $0.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results